Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study

Journal of Clinical Lipidology

Volumn 9, Issue 1, 2015, Pages 42-48

  Pang, Jing ^a   Sullivan, David R ^b   Harada Shiba, Mariko ^c   Ding, Phillip Y A ^d   Selvey, Sheryl ^e   Ali, Shariq ^e   Watts, Gerald F ^a,f  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e GENZYME CORPORATION   (United States)

^f ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Asia; Awareness; Familial hypercholesterolemia; Knowledge; Models of care; Perception; Physicians; Practices

Indexed keywords

LIPOPROTEIN A; CHOLESTEROL;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; AWARENESS; CARDIOLOGIST; CARDIOVASCULAR RISK; CLINICAL PRACTICE; ENDOCRINOLOGIST; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIRST DEGREE RELATIVE; GENERAL PRACTITIONER; HEALTH CARE SURVEY; HERITABILITY; HUMAN; INHERITANCE; JAPAN; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PATIENT CARE; PHYSICIAN; PHYSICIAN ATTITUDE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; RISK FACTOR; SCREENING; SMOKING; SOUTH KOREA; TAIWAN; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; HYPERLIPOPROTEINEMIA TYPE II; INTERNET; PSYCHOLOGY; QUESTIONNAIRE;

CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERNET; JAPAN; MALE; PHYSICIANS; PILOT PROJECTS; REPUBLIC OF KOREA; SURVEYS AND QUESTIONNAIRES; TAIWAN;

EID: 84927695878     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.09.011     Document Type: Article

References (26)

1. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478-3490.
2. Goldberg AC, Hopkins PN, Toth PP, et al. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:133-140.
3. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973;52:1544-1568.
4. Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF. Familial hypercholesterolemia in China: Prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol. 2014;174:834-836.
5. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication. J Clin Endocrinol Metab. 2012;97:3956-3964.
6. Hamilton-Craig I. Case-Finding for Familial Hypercholesterolemia in the Asia-Pacific Region. Semin Vasc Med. 2004;4:87-92.
7. Watts GF, Gidding S, Wierzbicki AS, et al. Integrated Guidance on the Care of Familial Hypercholesterolaemia from the International FH Foundation. Int J Cardiol. 2014;171:309-325.
8. Harada-Shiba M, Arai H, Oikawa S, et al. Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb. 2012;19:1043-1060.
9. Watts GF, Sullivan DR, Poplawski N, et al. Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements. 2011;12:221-263.
10. Foody JM. Familial Hypercholesterolemia: An Under-recognized but Significant Concern in Cardiology Practice. Clin Cardiol. 2013;37:119-125.
11. Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Br Med J. 2008;337:a2423.
12. Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, Scheerder RLJM, Kastelein JJP. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165-168.
13. Mabuchi H, Nohara A, Noguchi T, et al. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis. 2011;214:404-407.
14. Hu M, Lan W, Lam CW, Mak YT, Pang CP, Tomlinson B. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. Int J Cardiol. 2013;167:762-767.
15. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29:2625-2633.
16. Ueshima H, Sekikawa A, Miura K, et al. Cardiovascular Disease and Risk Factors in Asia A Selected Review. Circulation. 2008;118:2702-2709.
17. Jiang Y, Guo K, Chen M, Bao J, Shen C, Li Y. Serum lipoprotein(a) positively correlates with coronary artery calcification in low-risk chinese han patients: a study from a single center. PLoS One. 2013;8:e71673.
18. Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844-2853.
19. Hadfield SG, Horara S, Starr BJ, et al. Family tracing to identify patients with Familial Hypercholesterolaemia: the second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Ann Clin Biochem. 2009;46:24-32.
20. Watts GF, Sullivan DR, van Bockxmeer FM, et al. A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? Heart Lung Circ. 2012;21:543-550.
21. BellDA, Garton-Smith J, Vickery A, et al. Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia. Heart Lung Circ. 2014;23:309-313.
22. Jervise L, Hanson M, Bell D, Krass I, Watts GF. An audit of pharmacists' knowledge of familial hypercholesterolaemia: Implications for community healthcare. Australian Pharmacist. 2013;73-75.
23. Tai E, Ming Loh L, Sethi SK, Koay ES, Teng Lim Y, Tan C-E. MEDPED comes to Singapore. Atherosclerosis. 2001;154:252.
24. Nomura H, Nakayama T. The Japanese Healthcare System: The Issue Is To Solve The "Tragedy Of The Commons" Without Making Another. BMJ. 2005;331:648-649.
25. Ock SM, Choi JY, Cha YS, et al. The Use of Complementary and Alternative Medicine in a General Population in South Korea: Results from a National Survey in 2006. J Korean Med Sci. 2009;24:1-6.
26. Chen F-P, Chen T-J, Kung Y-Y, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7:26.